was marginally associated with higher serum vitamin B 12 levels: each 57-µmol/L (1.0-mg/dL) increase in serum ascorbic acid level was associated with a serum vitamin B 12 level increase of 27 pmol/L (36 pg/mL) (P = .10). In addition, serum ascorbic acid level was not associated with correlates of vitamin B 12 deficiency, such as higher MCV levels, macrocytosis (MCV Ͼ100), or lower hemoglobin concentrations. Serum ascorbic acid level was not independently associated with serum ferritin levels. However, among women only, serum ascorbic acid levels were associated in a nonlinear fashion with prevalence of elevated serum ferritin levels (P = .02). We found no association between serum ascorbic acid level and prevalence of kidney stones in women or men (both PϾ.05).
Conclusions: Serum ascorbic acid levels were not associated with decreased serum vitamin B 12 levels (or indicators of vitamin B 12 deficiency), prevalence of kidney stones, serum ferritin levels, or-among men-prevalence of elevated serum ferritin levels. Serum ascorbic acid levels were associated with prevalence of elevated serum ferritin levels among women. Although the clinical relevance of these findings is uncertain, it seems prudent to suggest that women with a genetic susceptibility to iron overload should consider moderating their intake of ascorbic acid. Med. 1999; 159:619-624 M ANY AMERICANS consume ascorbic acid supplements daily. 1 Although high levels of ascorbic acid ingestion have been judged safe in healthy persons, [2] [3] [4] concern has been raised regarding the relation of such ingestion to vitamin B 12 deficiency, iron overload, and kidney stones. [5] [6] [7] [8] Most studies that have examined these relations have analyzed data from small numbers of subjects 7, [9] [10] [11] [12] [13] [14] [15] or from laboratory experiments. 5, [16] [17] [18] The use of ascorbic acid supplements may have important public health implications, particularly if adverse health effects result as a consequence.
Arch Intern
To examine the relation of blood ascorbic acid level, which reflects usual dietary intake, to serum vitamin B 12 level, serum ferritin level, and kidney stones, we analyzed data from participants of the Second National Health and Nutrition Examination Survey (NHANES II), a study that surveyed a large random sample of the American population.
RESULTS
Baseline characteristics of women and men are presented in Table 1 . Men had higher dietary iron intakes and serum ferritin levels compared with women but roughly comparable serum vitamin B 12 levels. Approximately 3% of women and 5% of men reported a history of kidney stones. Prevalence of high serum ferritin levels was approximately 5% among women and 8% among men. A varying number of subjects in our sample gave a history of using vitamin C supplements, and, as ex-pected, participants with the highest serum ascorbic acid levels were more likely to report such use. Approximately 1% of participants in the lowest serum ascorbic acid quintile used supplements compared with 6% to 12% of participants in the highest quintile. Mean dietary ascorbic acid intakes for women and men were 94 mg/d and 105 mg/d, respectively.
We examined whether serum ascorbic acid level was associated with serum vitamin B 12 level in several models ( Table 2) . In univariate, age-adjusted, and multivariate models, serum ascorbic acid level was associated with higher serum levels of vitamin B 12 in women; in the multivariate model, each 57-µmol/L (1.0-mg/dL) increase in serum ascorbic acid level was independently associated with NHANES II was a national probability survey of more than  20 000 Americans conducted between 1976 and 1980. 19 Participants, whose age ranged from 3 to 74 years, were interviewed and examined by study personnel at 2 visits. 19 We analyzed data from adult participants between the ages of 20 and 74 years. Data were available from 10 735 participants who answered questions regarding a history of kidney stones. Serum vitamin B 12 levels and serum ferritin levels were available for 1798 participants and 3407 participants, respectively.
METHODS

SUBJECTS
MEASUREMENTS
NHANES II questionnaire data included self-reported age, race, sex, menopausal status, years of education completed, level of leisure time physical activity, history of smoking, level of alcohol intake, gout, and use of diuretic medications, hormones, and nutritional supplements. Nutrition data were collected using a food frequency questionnaire and 24-hour diet recall. We calculated body mass index (a measure of weight in kilograms divided by the square of height in meters) from weight and height data recorded during the physical examination. The questionnaires, dietary methods, and examination procedures used in NHANES II have been described elsewhere in detail. 19 Serum ascorbic acid levels were measured at the Centers for Disease Control and Prevention by the dinitrophenylhydrazine method using a standardized protocol. 20 Because there were a small number of extreme serum ascorbic acid values of questionable validity (ranging as high as 1028 µmol/L [18.1 mg/dL]), we excluded participants with ascorbic acid levels in the top 0.5% of the sample (n = 54). Ascorbic acid levels for the remaining 99.5% of the participants ranged from 6 to 153 µmol/L (0.1-2.7 mg/dL).
Serum vitamin B 12 levels were measured in a subgroup of participants using the radioassay method described by Gunter et al 20 and Lau et al. 21 Serum ferritin levels were measured at the University of Kansas Medical Center, Kansas City. For both serum vitamin B 12 and serum ferritin assays, a subsample of persons was selected as follows: all persons whose NHANES II numbers ended in 8 and persons with 1 or more abnormal hematologic values (red blood cell count, hemoglobin, hematocrit, red blood cell mean corpuscular volume [MCV] , white blood cell count). An additional ferritin subsample of participants was also randomly chosen at the end of the survey for ferritin analysis. 22 A 2-site immunoradiometric assay was performed and samples with high serum ferritin levels (Ͼ200 µg/L) and low serum ferritin levels (Ͻ20 µg/L) were reassayed. 22, 23 To identify participants with elevated serum ferritin levels, we used the age-and sex-specific cut points published by the NHANES II Expert Scientific Working Group on iron status of the US population. 22 These cut points were more than 200 µg/L in men and more than 150 µg/L in women aged 20 to 44 years; more than 300 µg/L in men and 200 µg/L in women aged 45 to 64 years; and more than 400 µg/L in men and more than 300 µg/L in women aged 65 to 74 years. 22 A history of kidney stones was established by a positive response to either of the following 2 questions: "Have you ever had kidney stones?" and "Did a doctor ever tell you that you had kidney stones or stones in the ureter?"
STATISTICAL METHODS
We examined the distribution of ascorbic acid concentrations and other variables of interest using sample weights. We used simple and multiple linear regression models to examine the relation of serum ascorbic acid level to serum vitamin B 12 level, hemoglobin concentration, MCV, and serum ferritin level. For the dichotomous outcomes, ie, presence of elevated serum ferritin levels and kidney stones, we used simple and multiple logistic regression models. Level of education, level of physical activity, and alcohol consumption were analyzed as ordinal variables in the multivariate models.
Analyses were performed using Stata software that included survey commands for the analysis of complex survey data. 24 We calculated linear regression coefficients and 95% confidence intervals (CIs) to estimate differences in serum vitamin B 12 level, hemoglobin concentration, MCV, and serum ferritin level associated with each 57-µmol/L (1.0-mg/dL) increase in serum ascorbic acid level. Odds ratios and their 95% CIs were calculated using logistic regression to estimate the relative prevalence of elevated serum ferritin levels and kidney stones. Hosmer-Lemeshow goodness-of-fit tests 25 modified for weighted data were performed using a SAS macro program. 26 Two-tailed P values of .05 were considered to be statistically significant, unadjusted for multiple comparisons. 27 Figures examining the relation of serum ascorbic acid level to serum vitamin B 12 level and hemoglobin concentration were calculated using linear and quadratic coefficients derived from linear regression models. Predicted levels of the outcome variables were calculated within each 6-µmol/L (0.1-mg/dL) serum ascorbic acid level and the lowess smoothing procedure was applied to produce the plots. 28 Figures that examined the association between serum ascorbic acid level and prevalence of elevated serum ferritin level were used to plot the adjusted prevalence of elevated serum ferritin level as a function of serum ascorbic acid level. Logistic coefficients were used to compute individual predicted probability of elevated serum ferritin level. Next, we computed the mean of these probabilities within each 6-µmol/L (0.1-mg/dL) serum ascorbic acid level and then applied the lowess smoothing procedure to produce the plots. a serum vitamin B 12 level increase of 60 pmol/L (81 pg/ mL) in women (PϽ.001). Among men, each 57-µmol/L (1.0-mg/dL) increase in serum ascorbic acid level was marginally associated with a serum vitamin B 12 level increase of 27 pmol/L (36 pg/mL) (P = .10). Multivariate models controlled for the effects of a number of variables, including age, race, smoking, alcohol consumption, and use of vitamin B supplements. Because we also identified significant curvilinear relations between serum ascorbic acid and serum vitamin B 12 levels (P = .09 in men and .04 in women) and because the proportion of variance explained by both the linear and nonlinear models was almost identical, we also present these relations using models containing linear and quadratic terms (Figure 1) .
Less than 1% of participants had low serum vitamin B 12 levels (Ͻ221 pmol/L [300 pg/mL]) consistent with vitamin B 12 deficiency. Serum ascorbic acid level was associated with a decreased prevalence of low serum vitamin B 12 levels in women (P = .001) but was not associated with prevalence of low serum vitamin B 12 levels in men (P = .58). Because the assay used in NHANES II cannot distinguish between active and inactive analogs of vitamin B 12 , we also examined whether serum ascorbic acid levels were associated with indicators of vitamin B 12 deficiency, such as hemoglobin concentration, red blood cell MCV, and macrocytosis (MCV Ͼ100). Among participants in whom measurements of serum vitamin B 12 were performed, we found no association between serum ascorbic acid level and hemoglobin concentrations in men (P = .34) but found a significant curvilinear relation among women (P = .001) (Figure 2) . We also examined whether serum ascorbic acid level was a correlate of red blood cell MCV and prevalence of macrocytosis. Serum ascorbic acid level was not associated with either MCV or macrocytosis in women or men (all PϾ.08). Furthermore, self-reported ascorbic acid supplement use was not independently associated with serum vitamin B 12 levels in either women (P = .92) or men (P = .11).
We also assessed the relation between serum ascorbic acid and ferritin levels ( Table 3) . In univariate models, serum ascorbic acid level was significantly associated with serum ferritin level among women (PϽ.01) but not among men (P = .99) The association between ascorbic acid and iron status among women was attenuated after multivariate adjustment (P = .05) and further attenuated after controlling for the additional effects of menopausal status and hormone use (P = .14). Serum ascorbic acid level was not associated with elevated serum ferritin levels in men (P = .59) ( Table 4) but was independently associated in a nonlinear fashion with elevated serum ferritin levels in women (P = .02) (Figure 3) . Women with the highest serum ascorbic acid levels (Ͼ116 µmol/L [Ͼ2.1 mg/dL]) had an approximately 2-fold increase in prevalence of elevated serum ferritin levels compared with women whose serum ascorbic acid levels ranged between 43 and 80 µmol/L (0.8 and 1.4 mg/dL). Ascorbic acid supplement use was not independently associated with serum ferritin levels or elevated serum ferritin levels among men (P = .34 and .83, respectively). Among women, there was no independent association between ascorbic acid supplement use and serum ferritin levels (P = .81), but we did observe a trend toward a lower prevalence of elevated serum ferritin levels with supplement use (P = .08). Approximately 3% of women and 5% of men reported a history of kidney stones. Serum ascorbic acid level was not associated with an increased prevalence of kidney stones in women (multivariate odds ratio = 0.78; 95% CI, 0.56-1.10; P = .15). A marginally significant inverse association was observed between serum ascorbic acid level and kidney stones in men (multivariate odds ratio, 0.72; 95% CI, 0.51-1.02; P = .06) ( Table 5) . No data were available regarding the chemical composition of the self-reported kidney stones. Ascorbic acid supplement use was not independently associated with prevalence of kidney stones in either women (P = .87) or men (P = .46).
COMMENT
Concern has been expressed that high levels of ascorbic acid consumption may be placing many Americans at risk for adverse health outcomes, such as vitamin B 12 deficiency, iron overload, and kidney stones. 5, 6 Several studies that have examined these issues were performed in a laboratory setting 5, [16] [17] [18] or on small numbers of subjects. 7, [9] [10] [11] [12] [13] [14] [15] Among a representative sample of the adult US population surveyed between 1976 and 1980, we found no evidence that higher serum ascorbic acid levels resulting from ascorbic acid consumption adversely affected serum vitamin B 12 levels, prevalence of kidney stones, or, among men, prevalence of elevated serum ferritin levels. We did, however, find a nonlinear relation between serum ascorbic acid level and prevalence of elevated serum ferritin levels among women, which appeared similar to the relation between serum ascorbic acid level and hemoglobin concentration among women.
SERUM VITAMIN B 12 LEVELS
Using the same vitamin B 12 radioassay used in NHANES II, Herbert and Jacob 5 reported that the addition of ascorbic acid to homogenized test meals resulted in the destruction of vitamin B 12 . These findings, however, could not be replicated. 16 Herbert and colleagues 11 later reported that 4 of 18 patients with spinal cord injury who received 2 g/d of ascorbic acid for periods up to several years were vitamin B 12 deficient. Others, however, have judged these findings to be, at least in part, the result of an artifact of the assay used to measure vitamin B 12 levels. 2 Examination of the relation of high intakes of ascorbic acid in 10 patients with spinal cord injury 29 and among 40 children with myelomeningoceles 30 failed to reveal an association between ascorbic acid and vitamin B 12 deficiency. To our knowledge, there have been no large population-based studies examining the relation of ascorbic acid to vitamin B 12 status. We found no evidence that serum ascorbic acid levels are associated inversely with serum vitamin B 12 levels. On the contrary, it appeared that higher ascorbic acid serum levels were, on average, associated with higher serum vitamin B 12 levels among women and men. These findings could be the result of a correlated intake of these nutrients, either in the diet or in nutritional supplements.
SERUM FERRITIN LEVELS
Although serum ferritin levels may be elevated as a consequence of inflammatory conditions, they generally reflect total body iron stores and are considered the best measure to assess iron status in epidemiologic studies. 31 Ascorbic acid enhances the absorption of nonheme iron 32 and, therefore, may aid in the treatment of iron-deficiency anemia. However, ascorbic acid may be detrimental to individuals who carry the gene for hemochromatosis. 8 In assessing the prevalence of elevated serum ferritin levels based on ageand sex-specific cut points, 22 we found no association between ascorbic acid and prevalence of elevated serum ferritin levels among men but observed a nonlinear relation among women. To our knowledge, the relation between ascorbic acid and elevated serum ferritin levels has not been Table 2 . *Multivariate models adjusted for age, race, body mass index, smoking, education level, alcohol intake, level of physical activity, dietary iron intake, and use of iron supplements (including pills and injections). For women, multivariate models also adjust for menopausal status and hormone use. CI indicates confidence interval.
†PϽ.01.
examined in other large population-based studies. One small nonrandomized study of 17 healthy college students revealed no adverse effect from high-dose ascorbic acid ingestion (2 g/d) on serum ferritin levels and iron stores. 14 The clinical significance of our findings in women is uncertain. Several reviews have concluded that, for most individuals, high levels of ascorbic acid consumption are safe. [2] [3] [4] Furthermore, other analyses of NHANES data have reported improved health outcomes and lower mortality rates among individuals with high serum or intake levels of ascorbic acid.
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KIDNEY STONES
Most kidney stones are composed of calcium oxalate or uric acid. Although not observed uniformly, 12, 36, 37 some studies have reported that urinary oxalate and uric acid excretion are increased by the ingestion or administration of large amounts of ascorbic acid. 2 Studies that examined the relation of ascorbic acid to oxalate and uric acid excretion have generally examined small numbers of subjects. 2 We were able to examine the relation of serum ascorbic acid level to history of kidney stones among a random sample of more than 10 000 Americans and found no evidence to indicate that high serum ascorbic acid levels increased the prevalence of kidney stones. On the contrary, among men, each 57-µmol/L (1.0-mg/dL) increase in serum ascorbic acid level was independently associated with an approximately 28% decrease in the prevalence of kidney stones (P = .06). These findings agree with the conclusions of others 2 that in general, high levels of ascorbic acid ingestion do not result in increased kidney stone formation and may, in fact, be associated with a decreased prevalence of kidney stones. 38 The main limitation of our study derives from the cross-sectional nature of the analyses. Thus, we cannot be certain that the outcomes did not affect ascorbic acid consumption and, in turn, serum ascorbic acid levels. For example, it is possible that persons with kidney stone disease decreased their ascorbic acid intake and consequently lowered their blood ascorbic acid level, thereby producing the ostensible protective association between ascorbic acid and kidney stones. Although we cannot exclude this possibility, it is also biologically plausible that ascorbic acid may, in fact, lower the risk of kidney stones by decreasing urinary calcium excretion. 13 Because most people are unlikely to know their serum ferritin level or vitamin B 12 level, it seems less probable that these associations resulted from individuals changing their ascorbic acid intake. The serum vitamin B 12 radiodilution assay used by NHANES II measures both biologically active and inactive vitamin B 12 analogs. 39 Hence, we cannot be certain that the higher levels of serum vitamin B 12 associated with serum ascorbic acid levels reflect higher levels of the biologically active form of the vitamin. However, Table 4 . examination of the reliability of the serum vitamin B 12 radiodilution assay, when compared with the microbiologic vitamin B 12 assay, suggests that the comparative rank order of serum values is likely to be similar across assays. 40 Higher serum ascorbic acid levels were not associated with lower hemoglobin concentrations, higher red blood cell MCVs, or increased prevalence of macrocytosis, which further suggests that serum ascorbic acid levels, which reflect ascorbic acid intake, are unlikely to be associated with decreased serum levels of biologically active vitamin B 12 . Although serum ascorbic acid levels reflect intake patterns over days to weeks, 41 we had only a single measurement of serum ascorbic acid, which may not reflect longer-term intake. Finally, because the genotype of participants is not known, we cannot comment on the relation of serum ascorbic acid levels to elevated serum ferritin levels among individuals categorized by their genetic susceptibility to iron overload.
There are 2 notable strengths to these analyses. First, NHANES II surveyed a large random sample of the US population using standardized procedures and protocols. Hence, our findings should be generalizable. Second, the measurement of serum ascorbic acid levels on such a large number of persons provides a more accurate and precise assessment of ascorbic acid status as a correlate of serum vitamin B 12 level, serum ferritin level, and history of kidney stones than studies using dietary and supplement estimates only.
Establishing the safety of high levels of ascorbic acid ingestion is of public health importance in view of the large percentage of Americans consuming supplements containing ascorbic acid. Our results suggest that ascorbic acid serum levels, reflecting a broad range of ascorbic acid intakes, do not adversely affect vitamin B 12 status, prevalence of kidney stones, or, among men, prevalence of elevated serum ferritin levels. Because women with the highest serum ascorbic acid levels had an increased prevalence of elevated serum ferritin levels, it seems prudent to recommend that women with a genetic susceptibility to iron overload moderate their consumption of ascorbic acid. Although our results should be interpreted cautiously in view of the cross-sectional nature of the study design, they do, in general, concur with the findings of other investigators.
